Chronic Myeloproliferative Neoplasms

In this video, Tania Jain, MBBS, director of the Immune Effector Cell Therapy Program and associate professor of oncology at Johns Hopkins University, explains why it is important to consider how myeloproliferative neoplasms treatment will affect a patient's quality of life.

In this video, Aaron T. Gerds, MD, MS, highlighted findings from a study presented at ASH Annual Meeting and Exposition that explored treating advanced myelofibrosis using the LSD1 inhibitor bomedemstat.